Apply innovative technologies to explore cancer genome

Current Opinion in Oncology

Volumn 17, Issue 1, 2005, Pages 33-38

  Shih, Ie Ming ^a   Wang, Tian Li ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Amplification; Array comparative genomic hybridization; Cancer genome; Deletion; Digital karyotyping; Mutation; Representational oligonucleotide microarray analysis

Indexed keywords

CANCER GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; DIGITAL KARYOTYPING; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; KARYOTYPING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SEQUENCE TAGGED SITE; TUMOR CELL;

CYTOGENETICS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENOME; HUMANS; IN SITU HYBRIDIZATION; KARYOTYPING; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 13144279272     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000147382.97085.e4     Document Type: Review

References (45)

1. Kinzler KW, Vogelstein B: The Genetic Basis of Human Cancer, edn 2. Edited by Kinzler KW, Vogelstein B. Toronto: McGrawHill; 2002:3-821.
2. Onyango P: Genomics and cancer. Curr Opin Oncol 2002, 14:79-85.
3. Keyomarsi K, Tucker SL, Bedrosian I: Cyclin E is a more powerful predictor of breast cancer outcome than proliferation. Nat Med 2003, 9:152.
4. Farley J, Smith LM, Darcy KM, et al.: Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study. Cancer Res 2003, 63:1235-1241.
5. Masood S, Bui MM: Prognostic and predictive value of HER2/neu oncogene in breast cancer. Microsc Res Tech 2002, 59:102-108.
6. Zhang HT, Wang Q, Greene MI, et al.: New perspectives on anti-HER2/neu therapeutics. Drug News Perspect 2000, 13:325-329.
7. Guo QM: DNA microarray and cancer. Curr Opin Oncol 2003, 15:36-43.
8. Velculescu VE, Zhang L, Vogelstein B, et al.: Serial analysis of gene expression. Science 1995, 270:484-487.
9. Wang TL, Maierhofer C, Speicher MR, et al.: Digital karyotyping. Proc Natl Acad Sci USA 2002, 99:16156-16161.
10. Saha S, Sparks AB, Rago C, et al.: Using the transcriptome to annotate the genome. Nat Biotechnol 2002, 20:508-512.
11. King BL, Carter D, Foellmer HG, et al.: Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines. Am J Pathol 1992, 140:23-31.
12. Hauptmann S, Denkert C, Koch I, et al.: Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol 2002, 33:632-641.
13. Rao PH, Harris CP, Yan Lu X, et al.: Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer 2002, 33:123-132.
14. Wang TL, Diaz LA Jr, Romans K, et al.: Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci USA 2004, 101:3089-3094. This article demonstrates an example by using digital karyotyping in searching for DNA copy alteration that is involved in drug resistance. Genome-wide analysis reveals a close association of TYMS gene amplification and clinical 5-FU resistance in colorectal carcinoma. The paper concludes that TYMS may serve as a useful prognosis marker in patients with colorectal cancer.
15. Pinkel D, Segraves R, Sudar D, et al.: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211.
16. Pollack JR, Perou CM, Alizadeh AA, et al.: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
17. Lucito R, West J, Reiner A, et al.: Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res 2000, 10:1726-1736.
18. Kallioniemi A, Kallioniemi OP, Sudar D, et al.: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821.
19. Albertson DG, Collins C, McCormick F, et al.: Chromosome aberrations in solid tumors. Nat Genet 2003, 34:369-376.
20. Albertson DG, Pinkel D: Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 2003, 12(spec no 2):R145-R152.
21. Paris PL, Albertson DG, Alers JC, et al.: High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol 2003, 162:763-770.
22. Snijders AM, Nowee ME, Fridlyand J, et al.: Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene 2003, 22:4281-4286.
23. Garnis C, Coe BP, Zhang L, et al.: Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 2004, 23:2582-2586.
24. Veltman JA, Fridlyand J, Pejavar S, et al.: Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003, 63:2872-2880.
25. Holzmann K, Kohlhammer H, Schwaenen C, et al.: Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 2004, 64:4428-4433.
26. Schwaenen C, Nessling M, Wessendorf S, et al.: Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004, 101:1039-1044.
27. Weiss MM, Snijders AM, Kuipers EJ, et al.: Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003, 200:320-326.
28. Weiss MM, Kuipers EJ, Postma C, et al.: Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003, 22:1872-1879.
29. Ishkanian AS, Malloff CA, Watson SK, et al.: A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004, 36:299-303. The investigators in this work demonstrate the feasibility of higher resolution of array CGH, which is made possible by using 32,433 overlapping BAC clones that cover the entire human genome.
30. Greshock J, Naylor TL, Margolin A, et al.: 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004, 14:179-187.
31. Wang J, Meza-Zepeda LA, Kresse SH, et al.: M-CGH: Analysing microarray-based CGH experiments. BMC Bioinformatics 2004, 5:74.
32. Lisitsyn N, Wigler M: Cloning the differences between two complex genomes. Science 1993, 259:946-951.
33. Lucito R, Healy J, Alexander J, et al.: Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 2003, 13:2291-2305. This is the original paper that described the principle, development, and application of ROMA.
34. Sebat J, Lakshmi B, Troge J, et al.: Large-scale copy number polymorphism in human genome. Science 2004, 305:525-528.
35. Wang TL, Rago C, Silliman N, et al.: Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci USA 2002, 99:3076-3080.
36. Bardelli A, Parsons DW, Silliman N, et al.: Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003, 300:949.
37. Samuels Y, Wang Z, Bardelli A, et al.: High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304:554.
38. Wang Z, Shen D, Parsons DW, et al.: Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004, 304:1164-1166. This article has surveyed the DNA sequences of protein tyrosine phosphatase (PTP) family in colorectal cancers and found somatic mutation in approximately 26% of cancers. Functional studies in vitro and in vivo further suggest the tumor suppressor function of one of the genes, PTPRT.
39. Davies H, Bignell GR, Cox C, et al.: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
40. Cohen Y, Xing M, Mambo E, et al.: BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003, 95:625-627.
41. Singer G, Oldt R 3rd, Cohen Y, et al.: Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003, 95:484-486. This paper documents mutations in either BRAF or KRAS genes in 61% of low-grade ovarian serous carcinoma, but none in 72 high-grade ovarian serous carcinomas. The results indicate that low-grade and high-grade ovarian tumors develop through distinct pathways.
42. De Preter K, Pattyn F, Berx G, et al.: Combined subtractive cDN A cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons. BMC Genomics 2004, 5:11.
43. Pollack JR, Sorlie T, Perou CM, et al.: Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002, 99:12963-12968.
44. Hyman E, Kauraniemi P, Hautaniemi S, et al.: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002, 62:6240-6245.
45. Redon R, Hussenet T, Bour G, et al.: Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res 2002, 62:6211-6217.